Over-the-counter access to oral contraceptives

Expert Review of Obstetrics and Gynecology

Volumn 6, Issue 5, 2011, Pages 501-508

  Grossman, Daniel ^a,b  

^a IBIS REPRODUCTIVE HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

access; oral contraceptives; over the counter; pharmacy

Indexed keywords

GESTAGEN; NON PRESCRIPTION DRUG; ORAL CONTRACEPTIVE AGENT;

CLINICAL EFFECTIVENESS; CLINICAL PHARMACY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; EVIDENCE BASED MEDICINE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH INSURANCE; HORMONAL CONTRACEPTION; HUMAN; HYPERTENSION; JAMAICA; KUWAIT; LOWEST INCOME GROUP; MEXICO; PHARMACIST ATTITUDE; PHYSICIAN ATTITUDE; PILL; REVIEW; THAILAND; WOMEN'S HEALTH;

EID: 80053135852     PISSN: 17474108     EISSN: 17474116     Source Type: Journal    
DOI: 10.1586/eog.11.50     Document Type: Review

References (46)

1. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect. Sex Reprod. Health 38(2), 90-96 (2006). (Pubitemid 43882311)
2. Frost JJ, Singh S, Finer LB. U.S. womens one-year contraceptive use patterns, 2004. Perspect. Sex Reprod. Health 39(1), 48-55 (2007).
3. Smith JD, Oakley D. Why do women miss oral contraceptive pills? An analysis of womens self-described reasons for missed pills. J. Midwifery Womens Health 50(5), 380-385 (2005). (Pubitemid 41264363)
4. Grossman D. Should the contraceptive pill be available without prescription? Yes. BMJ 337, a3044 (2008).
5. Centers for Disease Control and Prevention. U.S. medical eligibility criteria for contraceptive use. Morbid. Mortal. Weekly Rep. 59 (2010).
6. Grossman D, Fernandez L, Hopkins K, Amastae J, Garcia SG, Potter JE. Accuracy of self-screening for contraindications to combined oral contraceptive use. Obstet. Gynecol. 112(3), 572-578 (2008).
7. Grossman D, White K, Hopkins K, Amastae J, Shedlin M, Potter JE. Contraindications to combined oral contraceptives among over-the-counter compared with prescription users. Obstet. Gynecol. 117(3), 558-565 (2011).
8. Yeatman SE, Potter JE, Grossman DA. Over-the-counter access, changing WHO guidelines, and contraindicated oral contraceptive use in Mexico. Stud. Fam. Plann. 37(3), 197-204 (2006). (Pubitemid 44363683)
9. Zavala AS, Perez-Gonzales M, Miller P, Welsh M, Wilkens LR, Potts M. Reproductive risks in a community-based distribution program of oral contraceptives, Matamoros, Mexico. Stud. Fam. Plann. 18(5), 284-290 (1987).
10. Shotorbani S, Miller L, Blough DK, Gardner J. Agreement between womens and providers assessment of hormonal contraceptive risk factors. Contraception 73(5), 501-506 (2006).
11. Becker D, Garcia SG, Ellertson C. Do Mexico city pharmacy workers screen women for health risks when they sell oral contraceptive pills over-the-counter? Contraception 69(4), 295-299 (2004). (Pubitemid 38366461)
12. Tatum C, Garcia SG, Goldman L, Becker D. Valuable safeguard or unnecessary burden? Characterization of physician consultations for oral contraceptive use in Mexico city. Contraception 71(3), 208-213 (2005). (Pubitemid 40250204)
13. Khader YS, Rice J, John L, Abueita O. Oral contraceptive use and the risk of myocardial infarction: a meta-analysis. Contraception 68, 11-17 (2003). (Pubitemid 37271985)
14. Gillum L, Mamidipudi S, Johnston S. Ischaemic stroke risk with oral contraceptives: a meta-analysis. JAMA 284, 72-78 (2000). (Pubitemid 30445664)
15. Trussell J. Contraceptive failure in the United States. Contraception 83(5), 397-404 (2011).
16. Foster DG, Parvataneni R, de Bocanegra HT, Lewis C, Bradsberry M, Darney P. Number of oral contraceptive pill packages dispensed, method continuation, and costs. Obstet. Gynecol. 108(5), 1107-1114 (2006). (Pubitemid 44665404)
17. Foster DG, Hulett D, Bradsberry M, Darney P, Policar M. Number of oral contraceptive pill packages dispensed and subsequent unintended pregnancies. Obstet. Gynecol. 117(3), 566-572 (2011).
18. Shah MA, Shah NM, Al-Rahmani E, Behbehani J, Radovanovic Z. Over-the-counter use of oral contraceptives in Kuwait. Int. J. Gynaecol. Obstet. 73(3), 243-251 (2001). (Pubitemid 32455510)
19. Potter JE, White K, Hopkins K, Amastae J, Grossman D. Clinic versus over-the-counter access to oral contraception: choices women make along the US-Mexico border. Am. J. Pub. Health 100(6), 1130-1136 (2010).
20. Potter JE, McKinnon S, Hopkins K et al. Continuation of prescribed compared with over-the-counter oral contraceptives. Obstet. Gynecol. 117(3), 551-557 (2011).
21. Landau SC, Tapias MP, McGhee BT. Birth control within reach: a national survey on womens attitudes toward and interest in pharmacy access to hormonal contraception. Contraception 74(6), 463-470 (2006). (Pubitemid 46037536)
22. Grossman D, Fernandez L, Hopkins K, Amastae J, Potter JE. Perceptions of the safety of oral contraceptives among a predominantly Latina population in Texas. Contraception 81(3), 254-260 (2010).
23. McIntosh J, Rafie S, Wasik M et al. Changing oral contraceptives from prescription to over-the-counter status: an opinion statement of the womens health practice and research network of the american college of clinical pharmacy. Pharmacotherapy 31(4), 424-437 (2011).
24. Gardner JS, Miller L, Downing DF, Le S, Blough D, Shotorbani S. Pharmacist prescribing of hormonal contraceptives: results of the Direct Access study. J. Am. Pharm. Assoc. 48(2), 212-221 (2008).
25. Cackovic M, Paidas MJ. Should oral contraceptives be sold over-the-counter? No. Contemp. Ob. Gyn. 53(9), 63-73 (2008).
26. Stewart FH, Harper CC, Ellertson CE, Grimes DA, Sawaya GF, Trussell J. Clinical breast and pelvic examination requirements for hormonal contraception: current practice vs evidence. JAMA 285(17), 2232-2239 (2001). (Pubitemid 32416769)
27. Henderson JT, Sawaya GF, Blum M, Stratton L, Harper CC. Pelvic examinations and access to oral hormonal contraception. Obstet. Gynecol. 116(6), 1257-1264 (2010).
28. American college of obstetricians and gynecologists. ACOG Practice Bulletin No. 109: cervical cytology screening. Obstet. Gynecol. 114(6), 1409-1420 (2009).
29. Jarvis S. Should the contraceptive pill be available without prescription? BMJ 337, a3056 (2008).
30. Harper CC, Brown BA, Foster-Rosales A, Raine TR. Hormonal contraceptive method choice among young, low-income women. How important is the provider? Patient Educ. Couns. 81, 349-354 (2010).
31. Landau S, Besinque K, Chung F et al. Pharmacist interest in and attitudes toward direct pharmacy access to hormonal contraception in the United States. J. Am. Pharm. Assoc. 49(1), 43-50 (2009).
32. Liang SY, Grossman D, Phillips K. Womens current out-of-pocket expenditures and dispensing patterns for oral contraceptives. Contraception 83(6), 528-536 (2011).
33. Sullivan PW. Switching prescription drugs to over the counter: consumers may benefit financially in examples from the US. BMJ 330(7496), 904-905 (2005).
34. Gianfrancesco F, Manning B, Wang R. Effects of prescription to OTC switches on out-of-pocket health care costs and utilization. Drug Benefit Trends 14, 13-30, 44 (2002).
35. Black TR. Oral contraceptive prescription requirements and commercial availability in 45 developing countries. Stud. Fam. Plann. 5(8), 250-254 (1974).
36. Bailey J, Jimenez RA, Warren CW. Effect of supply source on oral contraceptive use in Mexico. Stud. Fam. Plann. 13(11), 343-349 (1982).
37. Ratanajamit C, Chongsuvivatwong V. Survey of knowledge and practice on oral contraceptive and emergency contraceptive pills of drugstore personnel in Hat Yai, Thailand. Pharmacoepidemiol. Drug Saf. 10(2), 149-156 (2001). (Pubitemid 32590946)
38. Chin-Quee DS, Cuthbertson C, Janowitz B. Over-the-counter pill provision: evidence from Jamaica. Stud. Fam. Plann. 37(2), 99-110 (2006). (Pubitemid 43905633)
39. Davidson LA, Pettis CT, Joiner AJ, Cook DM, Klugman CM. Religion and conscientious objection: a survey of pharmacists willingness to dispense medications. Soc. Sci. Med. 71(1), 161-165 (2010).
40. Grimes DA, Lopez LM, OBrien PA, Raymond EG. Progestin-only pills for contraception. Cochrane Database Syst. Rev. 1, CD007541 (2010).
41. Cleland K, Peipert JF, Westhoff C, Spear S, Trussell J. Family planning as a cost-saving preventive health service. N. Engl. J. Med. 364(18), e37 (2011).
42. Wazaify M, Shields E, Hughes CM, McElnay JC. Societal perspectives on over-the-counter (OTC) medicines. Fam. Pract. 22, 170-176 (2005). (Pubitemid 40533092)
43. NHS Southwark. Oral contraception pilot www.southwarkpct.nhs.uk/our- services/sexual-and-reproductive-health/oral- contraception-pilot (Accessed 15 April 2011)
44. Anekwe L. Most OTC oral contraceptives are given to new users. Pulse 19 March 2010 www.pulsetoday.co.uk/story.asp?sectionco de=23&storycode=4125507 (Accessed 15 April 2011)
45. Guttmacher Institute. State policies in brief: insurance coverage of contraceptives www.guttmacher.org/statecenter/spibs/spib-ICC.pdf (Accessed 9 July 2011)
46. US Department of Health and Human Services. Womens preventive services: required health plan coverage guidelines www.hrsa.gov/womensguidelines/(Accessed 23 August 2011)